This is a firm fixed-price delivery order contract awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,855.66, was awarded by the Defense Logistics Agency (DLA) for the supply of EXPAREL 133 MG/10 ML VIAL 10ML, a pharmaceutical product. The contract has an ultimate completion date of October 8, 2024.
DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. This single-award IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. This delivery order is issued under that larger IDC contract vehicle.
Generated 12/17/24, 9:27 AM